| Primary |
| Hiv Infection |
78.9% |
| Antiretroviral Therapy |
5.8% |
| Acquired Immunodeficiency Syndrome |
4.0% |
| Hiv Test Positive |
1.6% |
| Hypertension |
1.0% |
| Prophylaxis |
1.0% |
| Hepatitis C |
0.9% |
| Depression |
0.8% |
| Myocardial Infarction |
0.7% |
| Pain |
0.7% |
| Diarrhoea |
0.6% |
| Diabetes Mellitus |
0.6% |
| Medical Diet |
0.6% |
| Acute Hiv Infection |
0.5% |
| Drug Dependence |
0.5% |
| Hyperlipidaemia |
0.5% |
| Toxoplasmosis |
0.4% |
| Headache |
0.4% |
| Hepatitis C Virus Test |
0.4% |
| Insomnia |
0.4% |
|
| Nephrolithiasis |
16.9% |
| Pregnancy |
12.5% |
| Renal Colic |
9.2% |
| Renal Failure |
7.1% |
| Renal Failure Acute |
5.3% |
| Blood Bilirubin Increased |
4.6% |
| Jaundice |
4.6% |
| Vomiting |
3.9% |
| Weight Increased |
3.7% |
| Osteonecrosis |
3.5% |
| Adverse Event |
3.4% |
| Death |
3.1% |
| Rash |
3.1% |
| Transaminases Increased |
3.1% |
| Hepatitis |
2.8% |
| Hyperbilirubinaemia |
2.8% |
| Ocular Icterus |
2.7% |
| Premature Baby |
2.6% |
| Renal Impairment |
2.6% |
| Dysphagia |
2.5% |
|
| Secondary |
| Hiv Infection |
53.7% |
| Antiretroviral Therapy |
10.4% |
| Product Used For Unknown Indication |
8.0% |
| Drug Use For Unknown Indication |
5.4% |
| Drug Exposure During Pregnancy |
5.3% |
| Maternal Exposure Timing Unspecified |
4.7% |
| Antiviral Treatment |
3.4% |
| Acquired Immunodeficiency Syndrome |
1.8% |
| Hepatitis C |
0.9% |
| Hypertension |
0.8% |
| Hiv Test Positive |
0.8% |
| Maternal Exposure During Pregnancy |
0.8% |
| Retroviral Infection |
0.7% |
| Prophylaxis |
0.6% |
| Diabetes Mellitus |
0.6% |
| Mycobacterium Avium Complex Infection |
0.4% |
| Foetal Exposure During Pregnancy |
0.4% |
| Depression |
0.4% |
| Antifungal Prophylaxis |
0.4% |
| Cytomegalovirus Infection |
0.3% |
|
| Abortion Spontaneous |
14.0% |
| Drug Exposure During Pregnancy |
10.7% |
| Maternal Exposure During Pregnancy |
6.5% |
| Premature Baby |
5.3% |
| Stillbirth |
5.0% |
| Myocardial Infarction |
4.9% |
| Umbilical Cord Abnormality |
4.8% |
| Foetal Exposure During Pregnancy |
4.7% |
| Ventricular Septal Defect |
4.7% |
| Renal Colic |
4.4% |
| Jaundice |
4.1% |
| Vomiting |
4.1% |
| Renal Impairment |
3.9% |
| Renal Failure Acute |
3.8% |
| Pregnancy |
3.6% |
| Diabetes Mellitus |
3.5% |
| Osteonecrosis |
3.5% |
| Nephrolithiasis |
3.1% |
| Viral Load Increased |
3.0% |
| Weight Increased |
2.5% |
|
| Concomitant |
| Hiv Infection |
60.4% |
| Product Used For Unknown Indication |
9.6% |
| Hepatitis C |
6.4% |
| Acquired Immunodeficiency Syndrome |
4.5% |
| Drug Use For Unknown Indication |
4.3% |
| Drug Exposure During Pregnancy |
3.6% |
| Depression |
1.4% |
| Hiv Test Positive |
1.2% |
| Hypertension |
1.0% |
| Diabetes Mellitus |
0.9% |
| Anxiety |
0.9% |
| Antifungal Prophylaxis |
0.7% |
| Antiretroviral Therapy |
0.7% |
| Mycobacterium Avium Complex Infection |
0.7% |
| Insomnia |
0.6% |
| Prophylaxis |
0.6% |
| Pain |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Smoking Cessation Therapy |
0.6% |
| Asthma |
0.5% |
|
| Abortion Spontaneous |
11.0% |
| Myocardial Infarction |
9.2% |
| Vomiting |
8.3% |
| Rash |
6.4% |
| Weight Decreased |
6.4% |
| Thrombocytopenia |
5.5% |
| Renal Failure Acute |
5.3% |
| Anaemia |
4.4% |
| Pregnancy |
4.4% |
| Stillbirth |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Pyrexia |
3.9% |
| Death |
3.7% |
| Neutropenia |
3.4% |
| Renal Impairment |
3.4% |
| Renal Tubular Disorder |
3.4% |
| Small For Dates Baby |
3.4% |
| Weight Increased |
3.4% |
| Drug Exposure During Pregnancy |
3.0% |
| Osteonecrosis |
3.0% |
|
| Interacting |
| Hiv Infection |
41.7% |
| Infection |
15.9% |
| Drug Use For Unknown Indication |
15.1% |
| Product Used For Unknown Indication |
12.4% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Hypertension |
1.5% |
| Squamous Cell Carcinoma |
1.5% |
| Epilepsy |
1.2% |
| Hiv Test Positive |
1.2% |
| Retroviral Infection |
1.2% |
| Antiretroviral Therapy |
1.0% |
| Intervertebral Disc Degeneration |
1.0% |
| Hyperphosphataemia |
0.7% |
| Antibiotic Therapy |
0.5% |
| Asymptomatic Hiv Infection |
0.5% |
| Back Pain |
0.5% |
| Coronary Artery Disease |
0.5% |
| Crohn's Disease |
0.5% |
| Polysubstance Dependence |
0.5% |
| Schizoaffective Disorder |
0.5% |
|
| Drug Interaction |
36.5% |
| Renal Failure Chronic |
15.4% |
| Vomiting |
7.7% |
| Drug Level Increased |
3.8% |
| Overdose |
3.8% |
| Renal Failure |
3.8% |
| Skin Exfoliation |
3.8% |
| Cerebrovascular Accident |
1.9% |
| Condition Aggravated |
1.9% |
| Confusional State |
1.9% |
| Cushing's Syndrome |
1.9% |
| Hospitalisation |
1.9% |
| International Normalised Ratio Decreased |
1.9% |
| Migraine |
1.9% |
| Muscle Atrophy |
1.9% |
| Myoglobin Blood Increased |
1.9% |
| Neutropenia |
1.9% |
| Night Sweats |
1.9% |
| Pancreatitis Acute |
1.9% |
| Renal Failure Acute |
1.9% |
|
